Skip to main content

Paraneoplastic pemphigus associated with fludarabine use

Abstract

Paraneoplastic pemphigus is a severe mucocutaneous disease associated with B-cell lymphoproliferative disorders. A 51-yr-old man presented to the oncology clinic with mucocutaneous skin lesions after six cycles of fludarabine for non-Hodgkin’s lymphoma. A punch biopsy from the skin showed suprabasal acantholysis and blister formation in the epidermis and upper dermis. Direct immunofluorescence demonstrated intercellular IgG deposition in all epidermal layers and complement (C3) at the basement membrane. The indirect immunofluorescence on rat bladder showed intercellular binding of IgG. These findings were consistent with paraneoplastic pemphigus associated with fludarabine use. The temporal association between fludarabine use and paraneoplastic pemphigus suggests there is an etiopathological link between these two entities.

This is a preview of subscription content, access via your institution.

References

  1. Panteleeva GA. Paraneoplastic bullous dermatoses. Vestn Dermatol Venerol 1990;50–52.

  2. Anhalt GJ, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;323:1729–1735.

    PubMed  CAS  Article  Google Scholar 

  3. Bazarbachi A, Bachelez H, Dehen L, Delmer A, Zittoun R, Dubertret L. Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine. Ann Oncol 1995;6:730–731.

    PubMed  CAS  Google Scholar 

  4. Jardin F, Levesque H, Tilly H. Auto-immune manifestations in non-Hodgkin’s lymphoma. Rev Med Interne 2005;26:557–571.

    PubMed  CAS  Article  Google Scholar 

  5. Reich K, et al. Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus. Br J Dermatol. 1999;141:739–746.

    PubMed  Article  CAS  Google Scholar 

  6. O’Brien S, et al. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood 1993;82:1695–1700.

    PubMed  CAS  Google Scholar 

  7. Maung ZT, Wood AC, Jackson GH, Turner GE, Appleton AL, Hamilton PJ. Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia. Br J Haematol 1994;88: 649–652.

    PubMed  CAS  Google Scholar 

  8. Gooptu C, et al. Paraneoplastic pemphigus: an association with fludarabine? Br J Dermatol 2001;144:1255–1261.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mustafa Ozguroglu MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yildiz, O., Ozguroglu, M., Yanmaz, M.T. et al. Paraneoplastic pemphigus associated with fludarabine use. Med Oncol 24, 115–118 (2007). https://doi.org/10.1007/BF02685912

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02685912

Key Words

  • Non-Hodgkin’s lymphoma
  • fludarabine
  • paraneoplastic pemphigus